Clinical Trial Update: Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating autologous bone marrow endothelial cells combined with platelet-rich plasma extract for the treatment of critical limb ischemia, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetic Foot
• Gangrene
• Leg Ulcer
• Peripheral Artery Disease

Drugs mentioned

• Autologous bone marrow-derived endothelial cells (BM-ECs) for transplantation (bone marrow-derived endothelial cells)
• Platelet-rich plasma extract (platelet-rich plasma)

Snippet

Sponsor: South China Research Center for Stem Cell and Regenerative Medicine | Conditions: Leg Ulcer, Diabetic Foot | Phase 1 | Status: UNKNOWN